Search company, investor...
CMR Surgical company logo

CMR Surgical

Founded Year



Incubator/Accelerator | Alive

Total Raised


About CMR Surgical

CMR Surgical operates as a surgical robotics company developing universal robotic systems for minimal access surgery. It aims to make minimal-access surgery universally accessible and affordable by expanding the range of procedures that can be performed robotically. CMR Surgical was formerly known as Cambridge Medical Robotics. It was founded in 2014 and is based in Cambridge, United Kingdom.

Headquarters Location

1 Evolution Business Park Milton Road

Cambridge, England, CB24 9NG,

United Kingdom

+44 (0)1223 755 300

Missing: CMR Surgical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: CMR Surgical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing CMR Surgical

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned CMR Surgical in 5 CB Insights research briefs, most recently on Aug 9, 2022.

Expert Collections containing CMR Surgical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CMR Surgical is included in 6 Expert Collections, including Unicorns- Billion Dollar Startups.


Unicorns- Billion Dollar Startups

1,215 items



1,974 items

This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.


Medical Devices

9,288 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Digital Health 150

150 items

The winners of the second annual CB Insights Digital Health 150.


Digital Health

10,347 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.


Health IT

7,901 items

CMR Surgical Patents

CMR Surgical has filed 167 patents.

The 3 most popular patent topics include:

  • Surgery
  • Surgical instruments
  • Surgical robots
patents chart

Application Date

Grant Date


Related Topics




Surgery, Surgical instruments, Surgical robots, Health informatics, Telehealth


Application Date


Grant Date



Related Topics

Surgery, Surgical instruments, Surgical robots, Health informatics, Telehealth



Latest CMR Surgical News

Hypervision Surgical secures £6.50 million seed from investors led by HERAN Partners

Jun 5, 2023

“We are incredibly excited about the transformative potential of our Hyperspectral Intelligence platform,” said Michael Ebner, CEO and co-founder of Hypervision Surgical. “Imagine a complex tumour surgery where surgeons can rely on precise measurements and tissue property information to distinguish between healthy and unhealthy tissue. Our technology makes the invisible visible, empowering surgeons to make confident decisions with enhanced precision and ultimately improving patient outcomes.” The funding round was led by a syndicate of highly experienced European and American HealthTech investors, including HERAN Partners, Redalpine, LifeX Ventures, and ZEISS Ventures, the corporate venture arm of the ZEISS Group – a global technology leader operating in the fields of optics and optoelectronics. Raf Roelands, Investment Director at HERAN Partners, stated, “Hypervision Surgical’s hardware- agnostic solution has the potential to redefine the standard of care in surgical imaging across various procedures, from open to minimally invasive, robotics, and microscopic surgeries.” Daniel Dillinger, Investment Manager at Redalpine, emphasised, “Hypervision Surgical’s objective tissue characterisation and analytics platform is uniquely positioned to drive surgical decision- making and address critical unmet needs in the growing field of minimally invasive surgery, which sees nearly 200 million procedures annually.” Iñaki Berenguer, Founding Partner at LifeX Ventures, highlighted the potential impact, stating, “The innovation in AI-powered vision systems, with simplified deployment in hospitals, holds the key to significantly improving the lives of millions of patients undergoing critical surgeries. Hypervision Surgical has the necessary ingredients to lead in this category.” In conjunction with the funding announcement, Hypervision Surgical is delighted to welcome Martin Frost CBE, Founder and former CEO of CMR Surgical, to its board of directors. Frost has an extensive track record as a technology executive and director, having spent decades building and leading multiple companies, including through initial public offerings. Notably, he founded CMR Surgical in 2014 and swiftly scaled it into a globally recognised unicorn in the field of surgical robotics. In recognition of his exceptional contributions to Robotics and the British Industry, Frost was awarded a CBE in the 2020 Queen’s Birthday Honours. “We are thrilled to have Martin Frost join our board of directors,” said Michael Ebner. “His unparalleled expertise in building and scaling surgical technology ventures will be invaluable as we navigate the next phase of Hypervision Surgical’s growth and commercialisation efforts.” The newly secured funding will accelerate the development of Hypervision Surgical’s cutting- edge vision technology and be used to attain regulatory clearance in the United States and Europe. The company will expand collaborations with leading surgeons, renowned surgical centres, and strategic industry partners on both sides of the Atlantic to ensure a successful market launch and smooth integration into clinical practice. Additionally, the completion of UK clinical evaluation studies on colorectal and neurosurgery in the coming year will further enhance its evidence base. (adsbygoogle = window.adsbygoogle || []).push({}); About Hypervision Surgical Ltd Hypervision Surgical Ltd, a spin-out from King’s College London, is developing an intraoperative imaging system that seamlessly integrates into the surgical workflow for real-time tissue characterisation. Their goal is to revolutionise surgical outcomes through advanced computer-assisted analysis, enhancing precision and patient safety. For more information, visit HERAN Partners is a Belgium-based investment fund focused on supporting European start-ups and scale-ups in the MedTech and HealthTech industry. In addition to financial support, they provide a strong network, expertise, and mentorship in order to fuel growth at their portfolio companies. HERAN Partners currently manages its first fund of EUR 75,5m which targets ventures with highly-disruptive & scalable technologies. Redalpine is the Swiss venture capital firm that empowers Game Changers. Founded in 2006, Redalpine brings together financial investment, operational expertise, and a vast international network to help ambitious entrepreneurs transform their vision into a reality. With over €1bn in assets under management and a disciplined, sector-agnostic investment strategy, the firm has backed some of Europe’s most disruptive companies, including N26, Taxfix, Inkitt, 9fin, Carvolution, Zenjob, vivenu, and Umiami. Redalpine has over 85 companies in its portfolio and invests Europe-wide from its offices in Zurich and Berlin. LifeX Ventures is a New York-based venture capital firm investing in global visionary entrepreneurs using software and AI to develop transformational solutions that will extend the life of humans and the planet. With its $100M debut fund, LifeX is targeting the two largest sectors in the world: People (bio/health) and Planet (climate), where Software and AI suddenly matter. To learn more, please visit ZEISS Ventures, the corporate venture capital arm of the ZEISS Group, makes investments and actively manages a portfolio of startup companies. Our goal is to invest in and partner with deep-tech startups, which go beyond ZEISS’ core business and have the potential to disrupt and innovate existing technologies and business models. ZEISS Ventures aims to provide startups not only with the capital they need, but also with access to its resources, capabilities, and global network as a deep-tech corporation in order to foster and accelerate their development. For more information, visit

CMR Surgical Frequently Asked Questions (FAQ)

  • When was CMR Surgical founded?

    CMR Surgical was founded in 2014.

  • Where is CMR Surgical's headquarters?

    CMR Surgical's headquarters is located at 1 Evolution Business Park, Cambridge.

  • What is CMR Surgical's latest funding round?

    CMR Surgical's latest funding round is Incubator/Accelerator.

  • How much did CMR Surgical raise?

    CMR Surgical raised a total of $986.3M.

  • Who are the investors of CMR Surgical?

    Investors of CMR Surgical include ABHI US Accelerator, Cambridge Innovation Capital, Watrium, GE Healthcare, Chimera and 12 more.

  • Who are CMR Surgical's competitors?

    Competitors of CMR Surgical include Activ Surgical, Vicarious Surgical, Quantum Surgical, Medrobotics, Corindus Vascular Robotics and 11 more.

Compare CMR Surgical to Competitors


Medrobotics has developed a platform of flexible medical robots that enable surgeons to access, visualize, and perform two-handed surgery in hard-to-reach anatomical places through a single-site access. The core technology is a new generation of flexible robotic snakes with advanced vision systems that are able to navigate tortuous paths while providing accessory channels for a wide range of flexible surgical tools. The robots are self-supporting, which means they are able to support their own weight and move within any three-dimensional space without the need for any other structural support. The company was formerly known as Cardiorobotics and Innvoention Technologies.

Quantum Surgical Logo
Quantum Surgical

Quantum Surgical is a surgical robotics start-up building next-generation smart tools for minimally invasive therapies, beginning with interventional oncology. The robotic platform will enable physicians to better assess, plan, and treat a broad spectrum of medical conditions. The Company is developing end-to-end solutions for interventional oncology.

Activ Surgical

Activ Surgical is a digital surgery company that focuses on enhanced real-time visualization capabilities for surgeons. The company develops and strengthens software combining advanced augmented reality (AR), artificial intelligence (AI), and machine learning (ML) technology. Its products include ActivSight, ActivEdge, ActivPerfusion, and ActivICG. The company was founded in 2017 and is based in Boston, Massachusetts.

Intuitive Surgical

Intuitive Surgical develops, manufactures and markets robotic surgical systems under the da Vinci Surgical brand.

Bionaut Labs

Bionaut Labs is a biotech company that designs and manufactures intra- tissue navigation using Bionaut nano, microrobots operating inside the body. It develops tiny robots to deliver drugs into the brain, controlled by magnetic propulsion, to target hard-to-treat diseases. Its devices cater to therapeutic, microsurgical, diagnostic, sensing, monitoring, and stimulatory issues. The company was founded in 2016 and is based in Los Angeles, California.

Theator Logo

Theator leverage surgical intelligence solutions. The company develops software as a service (SaaS) platform to provide surgeons with artificial intelligence (AI) powered decision-support tools. It was founded in 2018 and is based in Palo Alto, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.